$4.03
00.00%
Last update: 4:02 PM
15 minutes delayed
Comments
Loading...
Telomir Pharmaceuticals
TELONASDAQ
Telomir Pharmaceuticals (TELO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestTelomir Pharmaceuticals (NASDAQ:TELO) Stock Quotes, Forecast and News Summary
Telomir Pharmaceuticals Stock (NASDAQ: TELO) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 39.02K |
| Day Range | - - - |
| 52 Wk Range | 3.51 - 20.72 |
| Market Cap | $119.33M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 42 |
| Short Interest | 0.24% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Telomir Pharmaceuticals Inc
Sector
Health Care
Industry
Pharmaceuticals
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the developmen...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Telomir Pharmaceuticals (TELO) stock?
You can purchase shares of Telomir Pharmaceuticals (NASDAQ:TELO) through any online brokerage.
Who are Telomir Pharmaceuticals (TELO) competitors?
Other companies in Telomir Pharmaceuticals’s space includes: Universe Pharmaceuticals (NASDAQ:UPC), SCYNEXIS (NASDAQ:SCYX), Marinus Pharma (NASDAQ:MRNS), Nutriband (NASDAQ:NTRB) and Trevi Therapeutics (NASDAQ:TRVI).
What is the target price for Telomir Pharmaceuticals (TELO) stock?
There is no analysis for Telomir Pharmaceuticals.
What is the forecast for Telomir Pharmaceuticals (TELO) stock?
There is no analysis for Telomir Pharmaceuticals to provide a consensus price target.
Current stock price for Telomir Pharmaceuticals (TELO)?
The stock price for Telomir Pharmaceuticals (NASDAQ: TELO) is $4.03 last updated July 23, 2024 at 4:02 PM EDT.
Does Telomir Pharmaceuticals (TELO) pay a dividend?
There are no upcoming dividends for Telomir Pharmaceuticals.
When is Telomir Pharmaceuticals (NASDAQ:TELO) reporting earnings?
Telomir Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 12, 2024.
Is Telomir Pharmaceuticals (TELO) going to split?
There is no upcoming split for Telomir Pharmaceuticals.
What sector and industry does Telomir Pharmaceuticals (TELO) operate in?
Telomir Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.